Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Drugs used to treat allergic conjunctivitis, prescription drugs and over-the-counter drugs are usually provided in the form of eye drops.
According to our research, the Allergic Conjunctivitis Drug market is expected to achieve significant growth during the forecast period. The report provides important information about the total valuation currently held by the industry, and also lists market segments and growth opportunities that exist in this business vertical.
The main factor affecting market growth is the rising prevalence of allergic conjunctivitis. In addition, increased health awareness, increased medical spending, increased exposure to allergens and infectious substances, and the infectious nature of the disease are expected to drive market growth.
The report details the trend, potential and market size of Allergic Conjunctivitis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Allergic Conjunctivitis Drugmarket, defines the market attractiveness level of Allergic Conjunctivitis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Allergic Conjunctivitis Drug industry, describes the types of Allergic Conjunctivitis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Allergic Conjunctivitis Drug market and the development prospects and opportunities of Allergic Conjunctivitis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Allergic Conjunctivitis Drug market in Chapter 13.
By Player:
Realm Therapeutics Plc
Xencor Inc
Re-Pharm Ltd
Accolade Pharmaceuticals LLC
Sylentis SAU
Aldeyra Therapeutics Inc
Clevexel Pharma SAS
Ohr Pharmaceutical Inc
Portola Pharmaceuticals Inc
Allergan Plc
AlleCures Inc
Griffin Discoveries BV
Ocular Therapeutix Inc
By Type:
CPC-888
CVXL-0074
ADX-102
AGN-229666
Dexamethasone Acetate SR
Others
By End-User:
Clinic
Research Center
Hospital
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Allergic Conjunctivitis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Allergic Conjunctivitis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Allergic Conjunctivitis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Allergic Conjunctivitis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Allergic Conjunctivitis Drug Market Analysis and Outlook to 2022
-
7.1 Global Allergic Conjunctivitis Drug Consumption (2017-2022)
-
7.2 United States Allergic Conjunctivitis Drug Consumption (2017-2022)
-
7.3 Europe Allergic Conjunctivitis Drug Consumption (2017-2022)
-
7.4 China Allergic Conjunctivitis Drug Consumption (2017-2022)
-
7.5 Japan Allergic Conjunctivitis Drug Consumption (2017-2022)
-
7.6 India Allergic Conjunctivitis Drug Consumption (2017-2022)
-
7.7 South Korea Allergic Conjunctivitis Drug Consumption (2017-2022)
8 Region and Country-wise Allergic Conjunctivitis Drug Market Analysis and Outlook to 2028
-
8.1 Global Allergic Conjunctivitis Drug Consumption Forecast (2022-2028)
-
8.2 United States Allergic Conjunctivitis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Allergic Conjunctivitis Drug Consumption Forecast (2022-2028)
-
8.4 China Allergic Conjunctivitis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Allergic Conjunctivitis Drug Consumption Forecast (2022-2028)
-
8.6 India Allergic Conjunctivitis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Allergic Conjunctivitis Drug Consumption Forecast (2022-2028)
9 Global Allergic Conjunctivitis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Allergic Conjunctivitis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CPC-888 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CVXL-0074 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global ADX-102 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global AGN-229666 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Dexamethasone Acetate SR Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Allergic Conjunctivitis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Center Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Allergic Conjunctivitis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Allergic Conjunctivitis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CPC-888 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CVXL-0074 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global ADX-102 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global AGN-229666 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Dexamethasone Acetate SR Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Allergic Conjunctivitis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Allergic Conjunctivitis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Allergic Conjunctivitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Allergic Conjunctivitis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Allergic Conjunctivitis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Allergic Conjunctivitis Drug Market Competitive Analysis
-
14.1 Realm Therapeutics Plc
-
14.1.1 Realm Therapeutics Plc Company Details
-
14.1.2 Realm Therapeutics Plc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Realm Therapeutics Plc Allergic Conjunctivitis Drug Product and Service
-
14.2 Xencor Inc
-
14.2.1 Xencor Inc Company Details
-
14.2.2 Xencor Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Xencor Inc Allergic Conjunctivitis Drug Product and Service
-
14.3 Re-Pharm Ltd
-
14.3.1 Re-Pharm Ltd Company Details
-
14.3.2 Re-Pharm Ltd Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Re-Pharm Ltd Allergic Conjunctivitis Drug Product and Service
-
14.4 Accolade Pharmaceuticals LLC
-
14.4.1 Accolade Pharmaceuticals LLC Company Details
-
14.4.2 Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Product and Service
-
14.5 Sylentis SAU
-
14.5.1 Sylentis SAU Company Details
-
14.5.2 Sylentis SAU Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sylentis SAU Allergic Conjunctivitis Drug Product and Service
-
14.6 Aldeyra Therapeutics Inc
-
14.6.1 Aldeyra Therapeutics Inc Company Details
-
14.6.2 Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Product and Service
-
14.7 Clevexel Pharma SAS
-
14.7.1 Clevexel Pharma SAS Company Details
-
14.7.2 Clevexel Pharma SAS Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Clevexel Pharma SAS Allergic Conjunctivitis Drug Product and Service
-
14.8 Ohr Pharmaceutical Inc
-
14.8.1 Ohr Pharmaceutical Inc Company Details
-
14.8.2 Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Product and Service
-
14.9 Portola Pharmaceuticals Inc
-
14.9.1 Portola Pharmaceuticals Inc Company Details
-
14.9.2 Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Product and Service
-
14.10 Allergan Plc
-
14.10.1 Allergan Plc Company Details
-
14.10.2 Allergan Plc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Allergan Plc Allergic Conjunctivitis Drug Product and Service
-
14.11 AlleCures Inc
-
14.11.1 AlleCures Inc Company Details
-
14.11.2 AlleCures Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 AlleCures Inc Allergic Conjunctivitis Drug Product and Service
-
14.12 Griffin Discoveries BV
-
14.12.1 Griffin Discoveries BV Company Details
-
14.12.2 Griffin Discoveries BV Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Griffin Discoveries BV Allergic Conjunctivitis Drug Product and Service
-
14.13 Ocular Therapeutix Inc
-
14.13.1 Ocular Therapeutix Inc Company Details
-
14.13.2 Ocular Therapeutix Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Ocular Therapeutix Inc Allergic Conjunctivitis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Allergic Conjunctivitis Drug
-
Figure Allergic Conjunctivitis Drug Picture
-
Table Global Allergic Conjunctivitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Allergic Conjunctivitis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Allergic Conjunctivitis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Allergic Conjunctivitis Drug Consumption by Country (2017-2022)
-
Figure United States Allergic Conjunctivitis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Allergic Conjunctivitis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Allergic Conjunctivitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Allergic Conjunctivitis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Allergic Conjunctivitis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Allergic Conjunctivitis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Allergic Conjunctivitis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Allergic Conjunctivitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Allergic Conjunctivitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Allergic Conjunctivitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Allergic Conjunctivitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Allergic Conjunctivitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Allergic Conjunctivitis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CPC-888 Consumption and Growth Rate (2017-2022)
-
Figure Global CVXL-0074 Consumption and Growth Rate (2017-2022)
-
Figure Global ADX-102 Consumption and Growth Rate (2017-2022)
-
Figure Global AGN-229666 Consumption and Growth Rate (2017-2022)
-
Figure Global Dexamethasone Acetate SR Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global CPC-888 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CVXL-0074 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ADX-102 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AGN-229666 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dexamethasone Acetate SR Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Allergic Conjunctivitis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Allergic Conjunctivitis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Realm Therapeutics Plc (Foundation Year, Company Profile and etc.)
-
Table Realm Therapeutics Plc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Realm Therapeutics Plc Allergic Conjunctivitis Drug Product and Service
-
Table Xencor Inc (Foundation Year, Company Profile and etc.)
-
Table Xencor Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Xencor Inc Allergic Conjunctivitis Drug Product and Service
-
Table Re-Pharm Ltd (Foundation Year, Company Profile and etc.)
-
Table Re-Pharm Ltd Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Re-Pharm Ltd Allergic Conjunctivitis Drug Product and Service
-
Table Accolade Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)
-
Table Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Product and Service
-
Table Sylentis SAU (Foundation Year, Company Profile and etc.)
-
Table Sylentis SAU Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sylentis SAU Allergic Conjunctivitis Drug Product and Service
-
Table Aldeyra Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Product and Service
-
Table Clevexel Pharma SAS (Foundation Year, Company Profile and etc.)
-
Table Clevexel Pharma SAS Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clevexel Pharma SAS Allergic Conjunctivitis Drug Product and Service
-
Table Ohr Pharmaceutical Inc (Foundation Year, Company Profile and etc.)
-
Table Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Product and Service
-
Table Portola Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Product and Service
-
Table Allergan Plc (Foundation Year, Company Profile and etc.)
-
Table Allergan Plc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Plc Allergic Conjunctivitis Drug Product and Service
-
Table AlleCures Inc (Foundation Year, Company Profile and etc.)
-
Table AlleCures Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AlleCures Inc Allergic Conjunctivitis Drug Product and Service
-
Table Griffin Discoveries BV (Foundation Year, Company Profile and etc.)
-
Table Griffin Discoveries BV Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Griffin Discoveries BV Allergic Conjunctivitis Drug Product and Service
-
Table Ocular Therapeutix Inc (Foundation Year, Company Profile and etc.)
-
Table Ocular Therapeutix Inc Allergic Conjunctivitis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ocular Therapeutix Inc Allergic Conjunctivitis Drug Product and Service
-
